TY - JOUR
T1 - The stereospecific incorporation of fenoprofen into rat hepatocyte and adipocyte triacylglycerols
AU - Sallustio, Benedetta C.
AU - Meffin, Peter J.
AU - Knights, Kathleen M.
PY - 1988/5/15
Y1 - 1988/5/15
N2 - The formation of triacylglycerols containing fenoprofen was studied in rat isolated adipocytes and hepatocytes incubated with [3H]glycerol and R or S fenoprofen. In both hepatocytes and adipocytes there was a high-affinity enzymatic process for the synthesis of triacylglycerol containing fenoprofen which was stereospecific for the R enantiomer. The apparent Km values for R fenoprofen were 1.0 μM in adipocytes and 2.8 μM in hepatocytes. These results are consistent with the proposed stereospecific formation of R-2-arylpropionyl-CoA thioesters resulting in the stereospecific formation of R-tri-acylglycerol at clinically relevant unbound fenoprofen concentrations. In isolated hepatocytes, but not adipocytes, a second low-affinity enzymatic process for the synthesis of triacylglycerol containing fenoprofen was also observed. However, this process (Km = 3780 μM) occurred at concentrations much higher than those found in man with usual doses.
AB - The formation of triacylglycerols containing fenoprofen was studied in rat isolated adipocytes and hepatocytes incubated with [3H]glycerol and R or S fenoprofen. In both hepatocytes and adipocytes there was a high-affinity enzymatic process for the synthesis of triacylglycerol containing fenoprofen which was stereospecific for the R enantiomer. The apparent Km values for R fenoprofen were 1.0 μM in adipocytes and 2.8 μM in hepatocytes. These results are consistent with the proposed stereospecific formation of R-2-arylpropionyl-CoA thioesters resulting in the stereospecific formation of R-tri-acylglycerol at clinically relevant unbound fenoprofen concentrations. In isolated hepatocytes, but not adipocytes, a second low-affinity enzymatic process for the synthesis of triacylglycerol containing fenoprofen was also observed. However, this process (Km = 3780 μM) occurred at concentrations much higher than those found in man with usual doses.
UR - http://www.scopus.com/inward/record.url?scp=0023947203&partnerID=8YFLogxK
U2 - 10.1016/0006-2952(88)90537-0
DO - 10.1016/0006-2952(88)90537-0
M3 - Article
C2 - 3377800
AN - SCOPUS:0023947203
SN - 0006-2952
VL - 37
SP - 1919
EP - 1923
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
IS - 10
ER -